Joseph H Donroe1, Elenore P Bhatraju2, Judith I Tsui2, E Jennifer Edelman3,4. 1. Yale School of Medicine, 1450 Chapel Street, Office MOB211, New Haven, CT, 06511, USA. joseph.donroe@yale.edu. 2. University of Washington School of Medicine, Seattle, WA, USA. 3. Yale School of Medicine, 1450 Chapel Street, Office MOB211, New Haven, CT, 06511, USA. 4. Yale Schools of Medicine and Public Health, E.S. Harkness Memorial Hall, Building A, 367 Cedar Street, Ste Suite 401, New Haven, CT, 06510, USA.
Abstract
PURPOSE OF REVIEW: The rising prevalence of opioid use disorder (OUD) and related complications in North America coupled with limited numbers of specialists in addiction medicine has led to large gaps in treatment. Primary care providers (PCPs) are ideally suited to diagnose and care for people with OUD and are increasingly being called upon to improve access to care. This review will highlight the recent literature pertaining to the care of patients with OUD by PCPs. RECENT FINDINGS: The prevalence of patients with OUD in primary care practice is increasing, and models of office-based opioid treatment (OBOT) are evolving to meet local needs of both ambulatory practices and patients. OBOT has been shown to increase access to care and demonstrates comparable outcomes when compared to more specialty-driven care. OBOT is an effective means of increasing access to care for patients with OUD. The ideal structure of OBOT depends on local factors. Future research must explore ways to increase the identification and diagnosis of patients with OUD, improve treatment retention rates, reduce stigma, and promote interdisciplinary approaches to care.
PURPOSE OF REVIEW: The rising prevalence of opioid use disorder (OUD) and related complications in North America coupled with limited numbers of specialists in addiction medicine has led to large gaps in treatment. Primary care providers (PCPs) are ideally suited to diagnose and care for people with OUD and are increasingly being called upon to improve access to care. This review will highlight the recent literature pertaining to the care of patients with OUD by PCPs. RECENT FINDINGS: The prevalence of patients with OUD in primary care practice is increasing, and models of office-based opioid treatment (OBOT) are evolving to meet local needs of both ambulatory practices and patients. OBOT has been shown to increase access to care and demonstrates comparable outcomes when compared to more specialty-driven care. OBOT is an effective means of increasing access to care for patients with OUD. The ideal structure of OBOT depends on local factors. Future research must explore ways to increase the identification and diagnosis of patients with OUD, improve treatment retention rates, reduce stigma, and promote interdisciplinary approaches to care.
Entities:
Keywords:
Buprenorphine; Opioid use disorder; Primary care
Authors: Gail D'Onofrio; Marek C Chawarski; Patrick G O'Connor; Michael V Pantalon; Susan H Busch; Patricia H Owens; Kathryn Hawk; Steven L Bernstein; David A Fiellin Journal: J Gen Intern Med Date: 2017-02-13 Impact factor: 5.128
Authors: Lisa Clemans-Cope; Jane B Wishner; Eva H Allen; Nicole Lallemand; Marni Epstein; Brenda C Spillman Journal: J Subst Abuse Treat Date: 2017-10-06
Authors: Marc R Larochelle; Dana Bernson; Thomas Land; Thomas J Stopka; Na Wang; Ziming Xuan; Sarah M Bagley; Jane M Liebschutz; Alexander Y Walley Journal: Ann Intern Med Date: 2018-06-19 Impact factor: 25.391
Authors: Elenore Patterson Bhatraju; Ellie Grossman; Babak Tofighi; Jennifer McNeely; Danae DiRocco; Mara Flannery; Ann Garment; Keith Goldfeld; Marc N Gourevitch; Joshua D Lee Journal: Addict Sci Clin Pract Date: 2017-02-28
Authors: Margo E Godersky; Andrew J Saxon; Joseph O Merrill; Jeffrey H Samet; Jane M Simoni; Judith I Tsui Journal: Addict Sci Clin Pract Date: 2019-03-13
Authors: Elizabeth J Austin; Elsa S Briggs; Lori Ferro; Paul Barry; Ashley Heald; Geoffrey M Curran; Andrew J Saxon; John Fortney; Anna D Ratzliff; Emily C Williams Journal: J Gen Intern Med Date: 2022-05-25 Impact factor: 6.473
Authors: Benjamin A Howell; Erica A Abel; Dongchan Park; Sara N Edmond; Leah J Leisch; William C Becker Journal: J Gen Intern Med Date: 2020-11-11 Impact factor: 5.128